FormBio

Form Bio provides an AI-driven computational platform that enhances cell and gene therapy development by optimizing therapeutic design and accelerating scientific discovery.

Founders

Ben Lamm, Kent Wakeford & Andrew Busey

Status

Active

Category

BioTech

Total Funding

$64.0M

HQ

Austin, TX

Founded

2022

About the company

Form Bio is a biotechnology company specializing in AI-powered computational platforms designed to accelerate cell and gene therapy development. Their proprietary FORMsight AI platform utilizes machine learning models to design and optimize therapeutic constructs, predict in vivo performance, and enhance manufacturability. By streamlining data management, workflows, and visualization, Form Bio empowers scientists to achieve breakthroughs more efficiently, reducing time and costs associated with developing safer and more effective therapies.